Profil bibliographique

Steven Schnittman

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

32Publications signalées

2962Citations signalées

1Affiliations récentes

Institutions déclarées

Biohaven Pharmaceuticals (United States)

Domaines associés

HIV Research and TreatmentHIV/AIDS drug development and treatmentHIV/AIDS Research and InterventionsHIV-related health complications and treatmentsHepatitis C virus research

Publications récentes

Accès ouvert 2025 conference-abstractOpenAlex

In depth characterization of autologous infused bhv-1100 armored memory-like NK cells in MRD+ multiple myeloma patients receiving autologous stem cell transplant

Grace Birch, Juliana Vergara-Cadavid, Alba Martini, Mubin Tarannum et autres

0 citationsBlood

2023 conference-abstractOpenAlex

Expansion, Persistence, and Characteristics of Autologous, Bhv-1100 Armored Memory-like NK Cells Infused Prior to Autologous Stem Cell Transplant in MRD+ Multiple Myeloma Patients: A First-in-Human Trial

Grace Birch, Juliana Vergara-Cadavid, Mohsin Maqbool, Alba Martini et autres

3 citationsBlood

2023 conference-abstractOpenAlex

P-004 Expansion, persistence, and characteristics of autologous, BHV-1100 ARMored memory-like NK cells infused prior to autologous stem cell transplant in MRD+, newly diagnosed multiple myeloma patients

Grace Birch, Juliana Vergara-Cadavid, Michela Ansuinelli, Tuyet Nguyen et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2016 book-chapterOpenAlex

Case History: The Discovery of the First Hepatitis C Virus NS5A Replication Complex Inhibitor Daclatasvir (Daklinza™)

Makonen Belema, Steven Schnittman, Nicholas A. Meanwell

3 citationsMedicinal chemistry reviews

2014 articleOpenAlex

Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study

Christophe Hézode, Gideon M. Hirschfield, Wayne Ghesquière, William Sievert et autres

119 citationsGut

2012 articleOpenAlex

Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial

Stanislas Pol, Reem Ghalib, Vinod K. Rustgi, Claudia Martorell et autres

148 citationsThe Lancet Infectious Diseases

Accès ouvert 2011 articleOpenAlex

Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents

Jennifer J. Kiser, Richard M. Rutstein, Pearl Samson, Bobbie Graham et autres

24 citationsAIDS

Accès ouvert 2010 articleOpenAlex

Prevalence and Clinical Significance of HIV Drug Resistance Mutations by Ultra-Deep Sequencing in Antiretroviral-Naïve Subjects in the CASTLE Study

Max Lataillade, Jennifer Chiarella, Rong Yang, Steven Schnittman et autres

131 citationsPLoS ONE

2006 articleOpenAlex

Gilbert Syndrome and the Development of Antiretroviral Therapy–Associated Hyperbilirubinemia: Genetic Screening Is Unnecessary

Richard E. Nettles, Michael Child, Richard Bertz, Steven Schnittman

12 citationsThe Journal of Infectious Diseases

2006 articleOpenAlex

Antiviral Activity of Nucleoside Analogues During Short-Course Monotherapy or Dual Therapy

Glenda Gray, Avye Violari, James McIntyre, Boris Jivkov et autres

20 citationsJAIDS Journal of Acquired Immune Deficiency Syndromes

2003 articleOpenAlex

Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial

David W. Haas, Carlos Zala, Shannon Schrader, Peter J. Piliero et autres

95 citationsAIDS

2003 articleOpenAlex

T cells containing T cell receptor excision circles are inversely related to HIV replication and are selectively and rapidly released into circulation with antiretroviral treatment

M Diaz, Daniel C. Douek, Hernán Valdez, Brenna J. Hill et autres

44 citationsAIDS

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.